High Vista Strategies LLC Verastem, Inc. Transaction History

High Vista Strategies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.05 - $3.2 $79,312 - $123,804	-38,689 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.54 - $4.07 $25,572 - $40,976	10,068 Added 35.18%	38,689 $119,000
Q2 2021 Aug 16, 2021	BUY	$2.57 - $4.85 $73,555 - $138,811	28,621 New	28,621 $117,000
Q3 2020 Nov 16, 2020	SELL	$1.11 - $1.68 $274,235 - $415,059	-247,059 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.69 - $4.2 $417,529 - $1.04 Million	247,059 New	247,059 $425,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $819M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.